Le Gouëllec A - Search Results

1

Central domain of DivIB caps the C-terminal regions of the FtsL/DivIC coiled-coil rod.

Masson S, Kern T, Le Gouëllec A, Giustini C, Simorre JP, Callow P, Vernet T, Gabel F, Zapun A. Masson S, et al. Among authors: le gouellec a. J Biol Chem. 2009 Oct 2;284(40):27687-700. doi: 10.1074/jbc.M109.019471. Epub 2009 Jul 27. J Biol Chem. 2009. PMID: 19635793 Free PMC article.

2

A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics.

Pernot L, Chesnel L, Le Gouellec A, Croizé J, Vernet T, Dideberg O, Dessen A. Pernot L, et al. Among authors: le gouellec a. J Biol Chem. 2004 Apr 16;279(16):16463-70. doi: 10.1074/jbc.M313492200. Epub 2004 Jan 20. J Biol Chem. 2004. PMID: 14734544 Free article.

3

Crystal structure of a peptidoglycan synthesis regulatory factor (PBP3) from Streptococcus pneumoniae.

Morlot C, Pernot L, Le Gouellec A, Di Guilmi AM, Vernet T, Dideberg O, Dessen A. Morlot C, et al. Among authors: le gouellec a. J Biol Chem. 2005 Apr 22;280(16):15984-91. doi: 10.1074/jbc.M408446200. Epub 2004 Dec 13. J Biol Chem. 2005. PMID: 15596446 Free article.

4

In vitro reconstitution of a trimeric complex of DivIB, DivIC and FtsL, and their transient co-localization at the division site in Streptococcus pneumoniae.

Noirclerc-Savoye M, Le Gouëllec A, Morlot C, Dideberg O, Vernet T, Zapun A. Noirclerc-Savoye M, et al. Among authors: le gouellec a. Mol Microbiol. 2005 Jan;55(2):413-24. doi: 10.1111/j.1365-2958.2004.04408.x. Mol Microbiol. 2005. PMID: 15659160 Free article.

5

Roles of pneumococcal DivIB in cell division.

Le Gouëllec A, Roux L, Fadda D, Massidda O, Vernet T, Zapun A. Le Gouëllec A, et al. J Bacteriol. 2008 Jul;190(13):4501-11. doi: 10.1128/JB.00376-08. Epub 2008 Apr 25. J Bacteriol. 2008. PMID: 18441058 Free PMC article.

6

Bacterial vectors for active immunotherapy reach clinical and industrial stages.

Le Gouëllec A, Chauchet X, Polack B, Buffat L, Toussaint B. Le Gouëllec A, et al. Hum Vaccin Immunother. 2012 Oct;8(10):1454-8. doi: 10.4161/hv.21429. Epub 2012 Aug 16. Hum Vaccin Immunother. 2012. PMID: 22894945 Free PMC article. Review.

7

A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.

Le Gouëllec A, Chauchet X, Laurin D, Aspord C, Verove J, Wang Y, Genestet C, Trocme C, Ahmadi M, Martin S, Broisat A, Cretin F, Ghezzi C, Polack B, Plumas J, Toussaint B. Le Gouëllec A, et al. Mol Ther. 2013 May;21(5):1076-86. doi: 10.1038/mt.2013.41. Epub 2013 Mar 26. Mol Ther. 2013. PMID: 23531551 Free PMC article.

8

What Is New in the Anti-Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert?

Reig S, Le Gouellec A, Bleves S. Reig S, et al. Among authors: le gouellec a. Front Cell Infect Microbiol. 2022 Jul 8;12:909731. doi: 10.3389/fcimb.2022.909731. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35880080 Free PMC article. Review.

9

Live-attenuated bacteria as a cancer vaccine vector.

Toussaint B, Chauchet X, Wang Y, Polack B, Le Gouëllec A. Toussaint B, et al. Among authors: le gouellec a. Expert Rev Vaccines. 2013 Oct;12(10):1139-54. doi: 10.1586/14760584.2013.836914. Expert Rev Vaccines. 2013. PMID: 24124876 Review.

10

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.

Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, Le Gouellec A. Bortolotti P, et al. Among authors: le gouellec a. BMC Microbiol. 2016 Jul 8;16(1):137. doi: 10.1186/s12866-016-0756-x. BMC Microbiol. 2016. PMID: 27392067 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page